QA: Enanta Pharmaceuticals INC in us_pharma/2014

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001177648_2015_Enanta_Pharmaceuticals_INC.pdf

Logs

Graph

Absolute values for 0001177648, Enanta Pharmaceuticals INC

  xvar xval
0 AssetsCurrent 107,975,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,803,000
3 remainder_Assets 45,637,000
4 LiabilitiesCurrent 4,746,000
5 LiabilitiesNoncurrent 229,000
6 remainder_Liabilities 1,786,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 10,016,000
9 ResearchAndDevelopmentExpense 18,740,000
10 remainder_Expenses -15,170,000
11 remainder_Revenues 47,741,000
12 remainder_NetIncome 283,000
13 remainder_ComprehensiveNetIncome -98,000
  yvar yval
0 Assets 155,415,000
1 Liabilities 6,761,000
2 Expenses 13,586,000
3 Revenues 47,741,000
4 StockholdersEquity 148,654,000
5 NetIncome 34,438,000
6 ComprehensiveNetIncome 34,389,000
7 BaseVar 111,942,000
8 EconomicCapitalRatiobeforeLimitedLiability 4.42
9 EconomicCapitalRatio 4.72

Edgar->Model Mapping

Feature Distribution

Change over Time